The number of antibiotic-resistant strains continues to rise rapidly. Statistics from the Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America (IDSA) point to alarming trends that are...
It is with great excitement that we unveil our network-wide redesign. Please read further to learn more about a few of our new features, and browse around to explore the new site!
Patients with heart failure and reduced ejection fraction (HF-REF) treated with an investigational angiotensin receptor neprilysin Inhibitor (ARNI) are more likely to reduce cardiovascular death and heart failure hospitalization than...
Teens who received the collaborative care intervention in primary care had significantly greater improvements in depressive symptoms than teens who were receiving treatment as usual.

FDA APPROVALS
FDA allows marketing of first ...

FDA has allowed marketing of the EnLite Neonatal TREC kit (PerkinElmer), the first newborn screening test for detection ...

Xtoro approved for swimmer's ear
Lynparza approved to treat advanced ...
FDA approves Viekira Pak to treat ...

CLINICAL
Lynparza approved to treat advanced ...

FDA has approved olaparib (Lynparza, AstraZeneca) for the treatment of women with advanced ovarian cancer associated with ...

FDA approves Viekira Pak to treat ...
FDA allows marketing of first ...
Xtoro approved for swimmer's ear

DRUGS IN PERSPECTIVE
Drugs in Perspective: Myalept ...

Myalept (metreleptin) is a leptin analogue with the same physiologic effects as leptin.11 Metreleptin was granted a ...

Drugs in Perspective: Otezla ...
Drugs in Perspective: Zykadia ...
Drugs in Perspective: Dalvance

Latest Tweets Follow